Anti-Human CD4 Therapeutic Antibody (Priliximab)
Recombinant monoclonal antibody to CD4. Priliximab (cMT 412) is a human-mouse chimeric anti-CD4 monoclonal antibody. It has been tested on patients with Crohn's disease and multiple sclerosis but has not yet received U.S. Food and Drug Administration licencing.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-164 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | CD4 |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | Suitable for use in IP, IF, FuncS, FC, Neut, ELISA, ICC and most other immunological methods. |
| Storage | 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided. |